Top Mark Capital Management reports Q3 2023 performance, highlighting returns from TMCP and TMHP partnerships, investment strategies, and a discussion on leadership’s role in long-term value.
Top Mark Capital Management reports Q3 2024 performance, highlighting returns from TMCP and TMHP partnerships, investment strategies, and a discussion on leadership’s role in long-term value.
The page analyzes yield curve inversions, focusing on the 10YR/2YR curve, market behavior during inversions, and the timing between inversions and recessions.
The 2022 Top Mark Capital Annual Letter outlines the firm’s investment philosophy, thematic analysis, and essays on compounding and behavioral biases in investing.
Top Mark Capital Partners (TMCP) and Top Mark Health Partners (TMHP) are private funds offered under Regulation D, restricted to accredited investors as defined by Rule 501(a).